-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2024-09-26
3020-OL:HK:HK-X DBMSCIUSA (HKD)
COMMON STOCK | Other |
Last Closing
USD 1325Change
+12.50 (+0.95)%Market Cap
N/AVolume
675.00Analyst Target
N/AN/A
Verdict
Values as of: 2024-09-26
COMMON STOCK | Other |
Last Closing
USD 1325Change
+12.50 (+0.95)%Market Cap
N/AVolume
675.00Analyst Target
N/AN/A
Verdict
There is no Profile data available for 3020-OL.HK.
Currency: HKD
Country : Hong Kong
Symbol | Name | Price(Change) | Market Cap |
---|---|---|---|
1863:HK | China Longevity Group Company .. |
N/A |
USD 1.17B |
8355:HK | I-CONTROL |
-0.01 (-1.47%) |
USD 0.39B |
8343:HK | HongGuang Lighting Holdings Co.. |
N/A |
USD 0.31B |
0648:HK | CHINA RENJ |
N/A |
USD 0.12B |
0177-OL:HK | JIANGSU EXPRESS |
-0.12 (-1.52%) |
N/A |
0240-OL:HK | BUILD KING HOLD |
+0.01 (+1.10%) |
N/A |
0243-OL:HK | QPL INT'L |
-0.01 (-8.90%) |
N/A |
0182-OL:HK | CHINA WINDPOWER |
+0.01 (+1.82%) |
N/A |
0259-OL:HK | YEEBO (INT'L H) |
-0.05 (-2.37%) |
N/A |
0187-OL:HK | JINGCHENG MAC |
+0.09 (+4.52%) |
N/A |
Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
---|---|---|---|---|---|
IHF | iShares U.S. Healthcare P.. | 7.69 % | 0.43 % |
-0.03 (1.04%) |
N/A |
TETF | 6.19 % | 0.64 % |
N/A |
N/A | |
IAI | iShares U.S. Broker-Deale.. | 4.70 % | 0.42 % |
+0.59 (+1.04%) |
N/A |
WBIF | WBI BullBear Value 3000 E.. | 4.47 % | 1.05 % |
+0.05 (+1.04%) |
N/A |
HDIV | 2.83 % | 0.00 % |
N/A |
N/A | |
UVAL:LSE | SPDR® MSCI USA Value UCI.. | 2.46 % | 0.00 % |
-0.03 (1.04%) |
USD 0.14B |
USVL:LSE | SPDR® MSCI USA Value UCI.. | 2.46 % | 0.00 % |
+0.27 (+1.04%) |
USD 0.14B |
FDWM | Fidelity Covington Trust .. | 1.76 % | 0.00 % |
+0.24 (+1.04%) |
USD 3.99M |
RYH | 1.72 % | 0.40 % |
N/A |
N/A | |
FSWD:LSE | iShares Edge MSCI World M.. | 1.50 % | 0.00 % |
-0.13 (1.04%) |
N/A |
IFSW:LSE | iShares Edge MSCI World M.. | 1.50 % | 0.00 % |
+0.03 (+1.04%) |
N/A |
IBCZ:F | iShares IV Public Limited.. | 1.47 % | 0.00 % |
+0.04 (+1.04%) |
N/A |
IS07:F | iShares IV Public Limited.. | 1.47 % | 0.00 % |
+0.07 (+1.04%) |
N/A |
JKH | 1.29 % | 0.30 % |
N/A |
N/A | |
HONR | 1.20 % | 0.65 % |
N/A |
N/A | |
VVL:CA | Vanguard Global Value Fac.. | 0.66 % | 0.40 % |
+0.69 (+1.04%) |
N/A |
SMD | 0.45 % | 0.10 % |
N/A |
N/A | |
ESGL | ESGL Holdings Limited Ord.. | 0.00 % | 0.40 % |
+0.17 (+1.04%) |
USD 0.07B |
DRFU:CA | Desjardins RI USA Multifa.. | 0.00 % | 0.57 % |
N/A |
CAD 5.97M |
SPVM | Invesco S&P 500 Value wit.. | 0.00 % | 0.39 % |
+0.47 (+1.04%) |
USD 0.09B |
RYF | 0.00 % | 0.40 % |
N/A |
N/A | |
XXM:CA | 0.00 % | 0.68 % |
N/A |
N/A | |
XMWD:LSE | Xtrackers MSCI World Swap.. | 0.00 % | 0.00 % |
+0.60 (+1.04%) |
N/A |
IMCG | iShares Morningstar Mid-C.. | 0.00 % | 0.00 % |
+0.65 (+1.04%) |
N/A |
Market Performance vs. Industry/Classification (Other) | Market Performance vs. Exchange | ||||||
Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
YTD | |||||||
Capital Gain | 22.80% | 84% | B | 83% | B | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | 22.80% | 80% | B- | 81% | B- | ||
Trailing 12 Months | |||||||
Capital Gain | 35.15% | 89% | A- | 86% | B+ | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | 35.15% | 87% | B+ | 85% | B | ||
Trailing 5 Years | |||||||
Capital Gain | 107.68% | 86% | B+ | 90% | A- | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | 107.68% | 86% | B+ | 89% | A- | ||
Average Annual (5 Year Horizon) | |||||||
Capital Gain | 16.19% | 81% | B- | 79% | B- | ||
Dividend Return | 16.19% | 77% | C+ | 77% | C+ | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Risk Return Profile | |||||||
Volatility (Standard Deviation) | 19.63% | 76% | C+ | 72% | C | ||
Risk Adjusted Return | 82.50% | 97% | N/A | 98% | N/A | ||
Market Capitalization | N/A | N/A | N/A | N/A | N/A |
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
There is nothing we particularly dislike